ChemCore Inc. aims to develop a point-of-care testing system based on microchip technology.
You may also be interested in...
GSK launches a 100% natural saline spray in the UK to compliment its Piri hayfever brand portfolio.
Progress for two US-based companies in the race to develop a COVID-19 vaccine.
MeMed has received CE Marking for its diagnostic test MeMed BV and point-of-need platform MeMed Key, which uses the human immune system to distinguish between bacterial and viral infections to prevent antibiotic overuse.